Page 4 - Genomics Systems News Today

Triatomic Management LP lessened its position in shares of Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating) by 33.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 155,411 shares of the company’s stock after selling 77,202 shares during the period. Triatomic Management LP […]

Revvity (NYSE:RVTY – Get Rating) and Singular Genomics Systems (NASDAQ:OMIC – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Analyst Recommendations This is a breakdown of recent ratings and […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) and Revvity (NYSE:RVTY – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings. Valuation and Earnings This table compares Singular Genomics Systems and […]

Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating) insider Eli N. Glezer purchased 170,000 shares of the stock in a transaction on Wednesday, May 17th. The stock was acquired at an average price of $0.82 per share, with a total value of $139,400.00. Following the completion of the acquisition, the insider now directly owns 4,355,000 […]

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Singular Genomics Systems (NASDAQ:OMIC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of […]

SAN DIEGO, May 09, 2023 -- Singular Genomics Systems, Inc. , a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, today... | May 9, 2023

09.05.2023 - SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) - Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent ...

The global genomic testing market is expected to grow from US$ 13.7 billion in 2022 to US$ 30.08 billion by 2031, at a CAGR of 9.54% over the forecast

New technologies, recognition, and the thrill of discovery propel the field’s largest public and private companies (plus eight up-and-comers).

06.02.2023 - The datasets are the latest to validate the performance and plug-and-play capability of the G4 across multiple applicationsSAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) - Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel ...